Syros Pharmaceuticals Inc (SYRS)
5.435
-0.04
(-0.82%)
USD |
NASDAQ |
May 17, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Total Assets (Quarterly): 134.73M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 134.73M |
December 31, 2023 | 168.17M |
September 30, 2023 | 147.80M |
June 30, 2023 | 180.98M |
March 31, 2023 | 205.32M |
December 31, 2022 | 244.49M |
September 30, 2022 | 284.72M |
June 30, 2022 | 126.23M |
March 31, 2022 | 152.08M |
December 31, 2021 | 182.94M |
September 30, 2021 | 208.04M |
June 30, 2021 | 233.73M |
March 31, 2021 | 260.63M |
December 31, 2020 | 213.25M |
September 30, 2020 | 133.34M |
June 30, 2020 | 147.82M |
March 31, 2020 | 161.40M |
Date | Value |
---|---|
December 31, 2019 | 149.98M |
September 30, 2019 | 143.83M |
June 30, 2019 | 151.83M |
March 31, 2019 | 88.43M |
December 31, 2018 | 106.77M |
September 30, 2018 | 120.63M |
June 30, 2018 | 131.38M |
March 31, 2018 | 128.10M |
December 31, 2017 | 78.49M |
September 30, 2017 | 88.68M |
June 30, 2017 | 99.03M |
March 31, 2017 | 78.02M |
December 31, 2016 | 91.32M |
September 30, 2016 | 100.41M |
June 30, 2016 | 60.95M |
March 31, 2016 | 70.82M |
December 31, 2015 | 43.63M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
126.23M
Minimum
Jun 2022
284.72M
Maximum
Sep 2022
181.57M
Average
164.79M
Median
Total Assets (Quarterly) Benchmarks
PAVmed Inc | 37.25M |
Moderna Inc | 16.73B |
Altimmune Inc | 188.36M |
iBio Inc | 34.02M |
Lixte Biotechnology Holdings Inc | 3.589M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 119.67M |
Shareholders Equity (Quarterly) | 15.06M |